search
Back to results

Acupuncture in the Freeze-all IVF Cycle

Primary Purpose

Acupuncture, Female Infertility

Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Acupuncture
Western medicine
Sponsored by
Peking University Third Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acupuncture focused on measuring Acupuncture, Traditional chinese medicine, freeze-all IVF cycle, Embryo Transfer

Eligibility Criteria

20 Years - 40 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  1. Meet the diagnostic criteria for infertility.
  2. Meet the criteria for identifying kidney deficiency in TCM.
  3. Patients who Planning to undergo IVF-ET for pregnancy in our center, Age ≤40 years and ≥25 years.
  4. Previous embryo transfer failure ≥ 2 times.
  5. Menstrual cycle is basically normal, and normal ovulation has been monitored in the past.
  6. There were more than 1 blastocyst /more than 2 high-quality embryos with more than 6 cells on day 3/more than 2 high-quality embryos with more than 4 cells on day 2.
  7. Consent to participate in this clinical trial and sign an informed consent form.

Exclusion Criteria:

  1. Patients with endometritis, acute pelvic inflammatory disease, mycotic vaginitis, bacterial vaginitis, adnexitis or other systemic infections.
  2. It has been confirmed that there are obvious and serious other organic lesions in the reproductive organs.
  3. Patients with allergic constitution
  4. Infertility caused by genetic factors
  5. Patients with serious primary diseases such as cardio cerebrovascular, kidney, liver and hematopoietic system and psychosis
  6. A person who is unable to cooperate (such as a combination of neurological or mental illness, or a reluctance to cooperate)
  7. The endometrial thickness on the day of hCG was less than 6 mm or the endometrial morphology on the day of hCG was type C
  8. Those who did not agree to participate in the study

Sites / Locations

  • Peking University Third HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Acupuncture treatment group

Western medicine group

Arm Description

Method: Acupuncture at Zhongwan、Qihai、Guanyuan、Zhongji、Guilai、Shenshu、Ciliao、Xuehai、Sanyinjiao、Taixi. The acupuncture treatment starts on the 5th day of the menstrual cycle and lasts to the days before IVF-ET

The western medicine group will be treated with conventional western medicine

Outcomes

Primary Outcome Measures

Clinical pregnancy rate (%)
Follow up by telephone calls 14days after the IVF-ET

Secondary Outcome Measures

Concentration of β-human Choriogonadotropin(β-HCG)
Obtained by blood sampling 14 days after the proposed IVF-ET

Full Information

First Posted
June 15, 2021
Last Updated
May 28, 2023
Sponsor
Peking University Third Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04931355
Brief Title
Acupuncture in the Freeze-all IVF Cycle
Official Title
A Randomized Controlled Study on the Short-term Intervention of Acupuncture in the Freeze-all IVF Cycle to Improve Pregnancy Rate
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 1, 2023 (Anticipated)
Primary Completion Date
December 30, 2024 (Anticipated)
Study Completion Date
December 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Peking University Third Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
In the early stage, our team found that Acupuncture intervention in freeze-all IVF cycles can improve the clinical pregnancy rate. In order to further study the role of Acupuncture in improving the pregnancy outcome of IVF-ET in infertility. A randomized controlled clinical trial will be used in this study. 90 infertile patients are randomly divided into two groups. The control group will be treated with conventional modern medicine, and the treatment group will be treated with Acupuncture on the basis of conventional modern medicine. The intervention starts from the 5th day of the menstrual cycle and lasts to the day before IVF-ET. The number of oocytes, antral follicles, AMH, serum FSH, and clinical pregnancy rate will be observed to evaluate the effect of Acupuncture on the improvement of pregnancy outcome. In addition, all of the participants will be asked to complete the self-evaluation of the anxiety/depression scale on the 7th day of the menstrual cycle, before and after transplantation, to analyze the emotional changes of the subjects during the study. We observe the safety and health economic indicators of Acupuncture treatment, so as to improve the overall efficacy of TCM Combined Application in assisted reproductive technology in the future.
Detailed Description
The study will be conducted on patients with DOR attending our reproductive medicine center for proposed IVF-ET between June 2021and December 2022. The trial is designed as a randomized, controlled clinical trial with two groups established by 1:1 equal allocation, a treatment group with interventions using acupuncture to tonify the kidneys and regulate blood and a control group treated using conventional Western medicine. Random numbers will be prepared by an independent third-party statistician who prepared a list of random group codes for this study. Enrolled subjects will be given a subject number during the screening process and, upon formal enrolment, will be randomly assigned to either the test or control group with a corresponding random number. The acupoints used will be: Zhongwan (RN12) :The needle should be punctured for 1-1.2 inches and retained for 30 minutes. Qihai(RN6): The needle should be punctured for 1-1.2 inches and retained for 30 minutes. Guanyuan(RN4): The needle should be punctured for 0.8-1.2 inches and retained for 30 minutes. Zhongji(RN3): The needle should be punctured for 0.8-1.0 inches and retained for 30 minutes. Guilai(ST29): The needle should be punctured for 0.8-1.0 inches and retained for 30 minutes. Shenshu(BL23): The needle should be punctured for 0.8-1.0 inches and retained for 30 minutes. Ciliao(BL28): The needle should be punctured for 1-1.2 inches and retained for 30 minutes. Xuehai(SP10): The needle should be punctured for 1-1.5 inches and retained for 30 minutes. Zusanli(ST36): The needle should be punctured for 1-1.5 inches and retained for 30 minutes. Diji(SP8): The needle should be punctured for 1-1.2 inches and retained for 30 minutes. Sanyinjiao(SP6): The needle should be punctured for 1-1.2 inches and retained for 30 minutes. Taixi(KI6): The needle should be punctured for 0.8-1.2 inches and retained for 30 minutes. Baihui(DU20): The needle should be punctured for 0.5-1.0 inches and retained for 30 minutes. Yintang(EX-HN3): The needle should be punctured for 0.5-1.0 inches and retained for 30 minutes. The Acupuncture intervention will start on the 5th day of the menstruation cycle, which will be carried out 1 time per day,at least 5 times a week, lasts for 10-15days. All operations were performed by experienced acupuncturists. After ET, both the control group and the treatment group will be treated with conventionally with no TCM intervention. Serum human chorionic gonadotropin (hCG) will be measured, and an hCG>30 IU will be considered to indicate biochemical pregnancy. Ultrasound monitoring will be performed 30 days after ET to calculate the clinical pregnancy rate.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acupuncture, Female Infertility
Keywords
Acupuncture, Traditional chinese medicine, freeze-all IVF cycle, Embryo Transfer

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
90 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Acupuncture treatment group
Arm Type
Experimental
Arm Description
Method: Acupuncture at Zhongwan、Qihai、Guanyuan、Zhongji、Guilai、Shenshu、Ciliao、Xuehai、Sanyinjiao、Taixi. The acupuncture treatment starts on the 5th day of the menstrual cycle and lasts to the days before IVF-ET
Arm Title
Western medicine group
Arm Type
Active Comparator
Arm Description
The western medicine group will be treated with conventional western medicine
Intervention Type
Other
Intervention Name(s)
Acupuncture
Other Intervention Name(s)
conventional western medicine(Recombinant Human Follitropin Alfa for Injection、Fructose Injection、Tetyacycline Hydrochloride Capsules、Cetrorelix Acetate Powder for Injection )
Intervention Description
The Acupuncture intervention(Zhongwan、Qihai、Guanyuan、Zhongji、Guilai、Shenshu、Ciliao、Xuehai、Sanyinjiao、Taixi.) will start on the 5th day of menstruation cycle, which will be carried out 1 time per day, at least 5 times a week, lasts for 10-15days. All operations were performed by experienced acupuncturists. After ET, both the control group and the treatment group will be treated with conventionally with no TCM intervention.
Intervention Type
Other
Intervention Name(s)
Western medicine
Intervention Description
Western medicine
Primary Outcome Measure Information:
Title
Clinical pregnancy rate (%)
Description
Follow up by telephone calls 14days after the IVF-ET
Time Frame
up to 6 weeks from enrollment
Secondary Outcome Measure Information:
Title
Concentration of β-human Choriogonadotropin(β-HCG)
Description
Obtained by blood sampling 14 days after the proposed IVF-ET
Time Frame
up to 6 weeks from enrollment
Other Pre-specified Outcome Measures:
Title
Changes from Baseline concentration of Self rating Anxiety Scale (SAS)
Description
They were completed on the 5th day of menstruation, before transplantation and the 14th day after transplantation.The score of 20 items is added to get the rough score (x), and after the formula is converted, that is, the whole part is taken after multiplying the rough score by 1.25, and then the standard score (y) will be obtained.According to the results of Chinese norm, the cut-off value of SAS standard deviation was 50 points, of which 50-59 points were mild anxiety, 60-69 points were moderate anxiety, and more than 69 points were severe anxiety.
Time Frame
The 5th day of menstruation、 Baseline the proposed IVF-ET、14 days after the IVF-ET
Title
Changes from Baseline concentration of Self rating Depression Scale (SDS)
Description
They were completed on the 5th day of menstruation, before transplantation and the 14th day after transplantation.The normal upper limit of SDS gross score is 41, and the lower the score, the better the state. The standard is divided into the integral part of the total rough score multiplied by 1.25. In China, SDS score ≥ 50 is regarded as depressive symptom.Severity of depression = cumulative score of each item / 80. Results: no depression was found in patients below 0.5; 5-0. 59 for mild to mild depression; 6-0. 69, moderate to severe; More than 0.7 was severe depression.
Time Frame
The 5th day of menstruation、 Baseline the proposed IVF-ET、14 days after the IVF-ET

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Meet the diagnostic criteria for infertility. Meet the criteria for identifying kidney deficiency in TCM. Patients who Planning to undergo IVF-ET for pregnancy in our center, Age ≤40 years and ≥25 years. Previous embryo transfer failure ≥ 2 times. Menstrual cycle is basically normal, and normal ovulation has been monitored in the past. There were more than 1 blastocyst /more than 2 high-quality embryos with more than 6 cells on day 3/more than 2 high-quality embryos with more than 4 cells on day 2. Consent to participate in this clinical trial and sign an informed consent form. Exclusion Criteria: Patients with endometritis, acute pelvic inflammatory disease, mycotic vaginitis, bacterial vaginitis, adnexitis or other systemic infections. It has been confirmed that there are obvious and serious other organic lesions in the reproductive organs. Patients with allergic constitution Infertility caused by genetic factors Patients with serious primary diseases such as cardio cerebrovascular, kidney, liver and hematopoietic system and psychosis A person who is unable to cooperate (such as a combination of neurological or mental illness, or a reluctance to cooperate) The endometrial thickness on the day of hCG was less than 6 mm or the endometrial morphology on the day of hCG was type C Those who did not agree to participate in the study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
xiyan xin, associate chief physician
Phone
+86 01082264623
Email
frw9606@163.com
First Name & Middle Initial & Last Name or Official Title & Degree
ruiwen Fan
Phone
+86 01082264623
Email
frw9606@163.com
Facility Information:
Facility Name
Peking University Third Hospital
City
Beijing, China
ZIP/Postal Code
100029
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
xiyan C xin

12. IPD Sharing Statement

Learn more about this trial

Acupuncture in the Freeze-all IVF Cycle

We'll reach out to this number within 24 hrs